IL141325A0 - Tan-1057 derivatives - Google Patents
Tan-1057 derivativesInfo
- Publication number
- IL141325A0 IL141325A0 IL14132599A IL14132599A IL141325A0 IL 141325 A0 IL141325 A0 IL 141325A0 IL 14132599 A IL14132599 A IL 14132599A IL 14132599 A IL14132599 A IL 14132599A IL 141325 A0 IL141325 A0 IL 141325A0
- Authority
- IL
- Israel
- Prior art keywords
- derivatives
- tan
- disorders
- humans
- animals
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/44—Nitrogen atoms not forming part of a nitro radical
- C07D233/48—Nitrogen atoms not forming part of a nitro radical with acyclic hydrocarbon or substituted acyclic hydrocarbon radicals, attached to said nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/14—Radicals substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/20—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D239/22—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Bakery Products And Manufacturing Methods Therefor (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19838998A DE19838998A1 (de) | 1998-08-27 | 1998-08-27 | Neue Naturstoffderivate |
| PCT/EP1999/006124 WO2000012484A1 (de) | 1998-08-27 | 1999-08-20 | Tan-1057 derivate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL141325A0 true IL141325A0 (en) | 2002-03-10 |
Family
ID=7878913
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL14132599A IL141325A0 (en) | 1998-08-27 | 1999-08-20 | Tan-1057 derivatives |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US6617332B1 (enExample) |
| EP (1) | EP1117652B1 (enExample) |
| JP (1) | JP4533535B2 (enExample) |
| KR (1) | KR20010099629A (enExample) |
| CN (1) | CN1324348A (enExample) |
| AT (1) | ATE267816T1 (enExample) |
| AU (1) | AU759618B2 (enExample) |
| BG (1) | BG105275A (enExample) |
| BR (1) | BR9913337A (enExample) |
| CA (1) | CA2342102C (enExample) |
| DE (2) | DE19838998A1 (enExample) |
| EE (1) | EE200100125A (enExample) |
| ES (1) | ES2219105T3 (enExample) |
| HK (1) | HK1041884A1 (enExample) |
| HR (1) | HRP20010135A2 (enExample) |
| HU (1) | HUP0103316A3 (enExample) |
| ID (1) | ID28365A (enExample) |
| IL (1) | IL141325A0 (enExample) |
| NO (1) | NO20010940L (enExample) |
| NZ (1) | NZ510153A (enExample) |
| PL (1) | PL346143A1 (enExample) |
| SK (1) | SK2622001A3 (enExample) |
| TR (1) | TR200100637T2 (enExample) |
| WO (1) | WO2000012484A1 (enExample) |
| ZA (1) | ZA200101038B (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1113008A1 (en) * | 1999-12-29 | 2001-07-04 | Pfizer Products Inc. | 4-oxo-2-ureido-1,4,5,6-tetrahydro-pyrimidine derivatives useful as antibacterial and antiprotozoal agents |
| US20040204404A1 (en) * | 2002-09-30 | 2004-10-14 | Robert Zelle | Human N-type calcium channel blockers |
| US8309724B2 (en) * | 2007-12-20 | 2012-11-13 | Dr. Reddy's Laboratories Limited | Processes for the preparation of sitagliptin and pharmaceutically acceptable salts thereof |
| WO2011046007A1 (ja) | 2009-10-15 | 2011-04-21 | 国立大学法人徳島大学 | ジエチレントリアミン五酢酸誘導体の製造方法およびジエチレントリアミン五酢酸誘導体 |
| CN102725274A (zh) * | 2009-10-16 | 2012-10-10 | Rib-X制药公司 | 抗微生物化合物和其制备和使用方法 |
| NZ599289A (en) | 2009-10-16 | 2014-11-28 | Melinta Therapeutics Inc | Antimicrobial compounds and methods of making and using the same |
| KR20190044136A (ko) | 2009-10-16 | 2019-04-29 | 멜린타 서브시디어리 코프. | 항미생물성 화합물 및 이의 제조 방법 및 사용 방법 |
| KR20120099435A (ko) * | 2009-10-16 | 2012-09-10 | 립-엑스 파마슈티칼즈, 인크. | 항미생물성 화합물 및 이의 제조 방법 및 사용 방법 |
| EA201391536A1 (ru) | 2011-04-15 | 2014-08-29 | Мелинта Терапьютикс, Инк. | Противомикробные соединения и способы их получения и применения |
| RU2475479C1 (ru) * | 2011-12-23 | 2013-02-20 | Федеральное государственное бюджетное учреждение Министерства здравоохранения и социального развития Российской Федерации "Медицинский радиологический научный центр" (ФГБУ МРНЦ Минздравсоцразвития России) | Вазоконстрикторное средство |
| SG10201801956SA (en) | 2013-09-09 | 2018-04-27 | Melinta Therapeutics Inc | Antimicrobial compounds and methods of making and using the same |
| EP3038623A4 (en) | 2013-09-09 | 2017-04-19 | Melinta Therapeutics, Inc. | Antimicrobial compounds and methods of making and using the same |
| JP2018507881A (ja) | 2015-03-11 | 2018-03-22 | メリンタ セラピューティクス，インコーポレイテッド | 抗微生物化合物ならびにこれらを作製および使用する方法 |
| CA3023317A1 (en) | 2016-05-06 | 2017-11-09 | Melinta Therapeutics, Inc. | Antimicrobials and methods of making and using same |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2873340B2 (ja) * | 1988-04-29 | 1999-03-24 | 武田薬品工業株式会社 | 抗生物質ｔａｎ―１０５７，その製造法および用途 |
| US6110925A (en) | 1997-08-07 | 2000-08-29 | Research Corporation Technologies, Inc. | Antibiotic for methicillin resistant bacteria |
-
1998
- 1998-08-27 DE DE19838998A patent/DE19838998A1/de not_active Ceased
-
1999
- 1999-08-20 EP EP99968234A patent/EP1117652B1/de not_active Expired - Lifetime
- 1999-08-20 DE DE59909607T patent/DE59909607D1/de not_active Expired - Lifetime
- 1999-08-20 HK HK02103758.4A patent/HK1041884A1/zh unknown
- 1999-08-20 WO PCT/EP1999/006124 patent/WO2000012484A1/de not_active Ceased
- 1999-08-20 HR HR20010135A patent/HRP20010135A2/hr not_active Application Discontinuation
- 1999-08-20 SK SK262-2001A patent/SK2622001A3/sk unknown
- 1999-08-20 CN CN99812643A patent/CN1324348A/zh active Pending
- 1999-08-20 AT AT99968234T patent/ATE267816T1/de not_active IP Right Cessation
- 1999-08-20 AU AU10099/00A patent/AU759618B2/en not_active Ceased
- 1999-08-20 PL PL99346143A patent/PL346143A1/xx not_active Application Discontinuation
- 1999-08-20 ID IDW20010483A patent/ID28365A/id unknown
- 1999-08-20 US US09/763,711 patent/US6617332B1/en not_active Expired - Fee Related
- 1999-08-20 TR TR2001/00637T patent/TR200100637T2/xx unknown
- 1999-08-20 EE EEP200100125A patent/EE200100125A/xx unknown
- 1999-08-20 KR KR1020017002417A patent/KR20010099629A/ko not_active Withdrawn
- 1999-08-20 IL IL14132599A patent/IL141325A0/xx unknown
- 1999-08-20 BR BR9913337-7A patent/BR9913337A/pt not_active IP Right Cessation
- 1999-08-20 ES ES99968234T patent/ES2219105T3/es not_active Expired - Lifetime
- 1999-08-20 NZ NZ510153A patent/NZ510153A/xx unknown
- 1999-08-20 CA CA002342102A patent/CA2342102C/en not_active Expired - Fee Related
- 1999-08-20 HU HU0103316A patent/HUP0103316A3/hu unknown
- 1999-08-20 JP JP2000567514A patent/JP4533535B2/ja not_active Expired - Fee Related
-
2001
- 2001-02-07 ZA ZA200101038A patent/ZA200101038B/en unknown
- 2001-02-20 BG BG105275A patent/BG105275A/xx unknown
- 2001-02-23 NO NO20010940A patent/NO20010940L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP4533535B2 (ja) | 2010-09-01 |
| WO2000012484A1 (de) | 2000-03-09 |
| ES2219105T3 (es) | 2004-11-16 |
| CA2342102A1 (en) | 2000-03-09 |
| HK1041884A1 (zh) | 2002-07-26 |
| AU759618B2 (en) | 2003-04-17 |
| ZA200101038B (en) | 2002-02-07 |
| DE19838998A1 (de) | 2000-03-09 |
| US6617332B1 (en) | 2003-09-09 |
| EP1117652B1 (de) | 2004-05-26 |
| ID28365A (id) | 2001-05-17 |
| HRP20010135A2 (en) | 2002-02-28 |
| NZ510153A (en) | 2002-12-20 |
| BR9913337A (pt) | 2001-05-15 |
| EE200100125A (et) | 2002-06-17 |
| NO20010940D0 (no) | 2001-02-23 |
| NO20010940L (no) | 2001-04-23 |
| BG105275A (en) | 2001-11-30 |
| ATE267816T1 (de) | 2004-06-15 |
| PL346143A1 (en) | 2002-01-28 |
| CA2342102C (en) | 2008-10-28 |
| EP1117652A1 (de) | 2001-07-25 |
| HUP0103316A2 (hu) | 2002-04-29 |
| AU1009900A (en) | 2000-03-21 |
| JP2002523496A (ja) | 2002-07-30 |
| HUP0103316A3 (en) | 2002-06-28 |
| KR20010099629A (ko) | 2001-11-09 |
| SK2622001A3 (en) | 2001-11-06 |
| TR200100637T2 (tr) | 2001-10-22 |
| DE59909607D1 (de) | 2004-07-01 |
| CN1324348A (zh) | 2001-11-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY124122A (en) | Heterocyclic derivatives | |
| MX9604378A (es) | Amidas de acido quinolin-2-carboxilico sustituidas, su preparacion y su empleo como medicamentos, asi como productos intermedios. | |
| MXPA02007942A (es) | Derivados de pirrolopirimidinona, procesos de preparacion y uso. | |
| IL162214A0 (en) | Pyridine derivatives and pharmaceutical compositions containing the same | |
| HK1038744A1 (zh) | 用於治療炎性疾病的化合物 | |
| BG105588A (en) | Anthranilic acide amides and the use thereof as medicaments | |
| MY133392A (en) | Novel substituted pyrazole derivatives | |
| BG103518A (en) | 2-(purin-9-yl)tetrahydrofuran-3,4-diol derivatives | |
| DK1200418T3 (da) | Nematodicide trifluorbutener | |
| PL367682A1 (en) | Dolastatin 10 derivatives | |
| GB9715894D0 (en) | Heterocyclic derivatives | |
| MY115211A (en) | Novel amino acid derivatives, their preparation and use | |
| AP2000001947A0 (en) | Novel crystalline forms of an antiviral benzidazole compound. | |
| MY120976A (en) | 2-amino-6-(2-substituted-4-phenoxy)- substituted- pyridines | |
| TNSN04034A1 (en) | Combined preparations, containing 1,4-benzothiepine-1,1-dioxide derivatives and other active substances, and the use thereof | |
| PL346143A1 (en) | Tan-1057 derivatives | |
| BG106155A (en) | Novel derivatives and analogues of galanthamin | |
| CA2415354A1 (en) | Phospholipid derivatives of valproic acid and mixtures thereof | |
| UA49884C2 (uk) | ПОХІДНІ <font face="Symbol">a</font>-ГІДРОКСИКАРБОНОВОЇ КИСЛОТИ ТА ЛІКАРСЬКИЙ ЗАСІБ НА ЇХ ОСНОВІ | |
| GB9809349D0 (en) | Heterocyclic derivatives | |
| MXPA04005552A (es) | Analogos de vitamina d. | |
| IL162314A (en) | Pyridine-2,4-dicarboxylic acid diamides and pyrimidine-4,6-dicarboxylic acid diamides, processes for their preparation, pharmaceutical compositions comprising them and uses thereof | |
| BG103260A (en) | The application of 1-hydroxy-2-pyridons for the treatment of seborrheic dermatitis | |
| SI1196129T1 (sl) | Farmacevtski in kozmeticni sestavki, ki obsegajo derivate urokaninske kisline kot odstranjevalce radikalov ali antioksidante | |
| MXPA03010259A (es) | Nuevos derivados de 5-tio-ss-d-xilopiranosida, procedimiento de preparacion, composiciones farmaceuticas que los contienen y el uso terapeutico de los mismos. |